DRAFT INTERNATIONAL STANDARD ISO/DIS 7886-3 ISO/TC 84 Sterile hypodermic syringes for single use Part 3: Auto-disabled syringes for fixed-dose immunization Seringues hypodermiques stériles, non réutilisables Partie 3: Seringues autobloquantes pour vaccination à dose fixe Secretariat: DS Voting begins on: Voting terminates on: 2016-11-28 2017-02-19 ICS: 11.040.25 THIS DOCUMENT IS A DRAFT CIRCULATED FOR COMMENT AND APPROVAL. IT IS THEREFORE SUBJECT TO CHANGE AND MAY NOT BE REFERRED TO AS AN INTERNATIONAL STANDARD UNTIL PUBLISHED AS SUCH. IN ADDITION TO THEIR EVALUATION AS BEING ACCEPTABLE FOR INDUSTRIAL, TECHNOLOGICAL, COMMERCIAL AND USER PURPOSES, DRAFT INTERNATIONAL STANDARDS MAY ON OCCASION HAVE TO BE CONSIDERED IN THE LIGHT OF THEIR POTENTIAL TO BECOME STANDARDS TO WHICH REFERENCE MAY BE MADE IN NATIONAL REGULATIONS. This document is circulated as received from the committee secretariat. ISO/CEN PARALLEL PROCESSING RECIPIENTS OF THIS DRAFT ARE INVITED TO SUBMIT, WITH THEIR COMMENTS, NOTIFICATION OF ANY RELEVANT Downloaded: PATENT 2016-11-28 RIGHTS OF WHICH THEY ARE AWARE Single AND user TO licence only, copying and networking prohibited PROVIDE SUPPORTING DOCUMENTATION. Reference number ISO/DIS 7886-3:2016(E) ISO 2016
ISO/DIS 7886-3:2016(E) COPYRIGHT PROTECTED DOCUMENT ISO 2016, Published in Switzerland All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting on the internet or an intranet, without prior written permission. Permission can be requested from either ISO at the address below or ISO s member body in the country of the requester. ISO copyright office Ch. de Blandonnet 8 CP 401 CH-1214 Vernier, Geneva, Switzerland Tel. +41 22 749 01 11 Fax +41 22 749 09 47 copyright@iso.org www.iso.org ii ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) Contents Page Foreword...v Introduction...vi 1 Scope... 1 2 Normative references... 1 3 Terms and definitions... 2 4 Nomenclature... 2 5 Requirements... 3 5.1 General Requirements... 3 6 Cleanliness... 4 7 Limits for acidity or alkalinity... 4 8 Limits for extractable metals... 4 9 Lubricant... 4 10 Tolerance on nominal capacity... 4 11 Graduated scale... 5 11.1 Scale... 5 11.2 Position of scale... 5 12 Barrel... 5 12.1 Dimensions... 5 12.2 Barrel flanges... 5 13 Plunger stopper/plunger assembly... 5 13.1 Design... 5 13.2 Fit of the plunger stopper/plunger in the barrel... 6 13.3 Fiducial line... 6 14 Needle... 6 14.1 Integrated needle... 6 14.2 Non-integrated needle... 6 14.3 Sharps protection features... 6 15 Performance... 7 15.1 General... 7 15.2 Dead space... 7 15.3 Freedom from air and liquid leakage... 7 15.4 Auto-disable feature... 7 15.5 Performance after shipping... 7 15.6 Guidance on materials... 7 16 Packaging... 8 16.1 Unit packaging providing sterile barrier... 8 16.2 User packaging... 8 17 Information supplied by the manufacturer... 8 17.1 General... 8 17.2 Syringes... 8 17.3 Unit packaging providing sterile barrier... 8 17.4 User packaging... 9 17.5 Storage containers... 9 17.6 Transport wrapping...10 Annex A (normative) Method for preparation of extracts...12 Annex B (informative) Licensed Test method to: Rundgren, for forces Mattis Mr required to operate piston...13 ISO 2016 All rights reserved iii
ISO/DIS 7886-3:2016(E) Annex C (normative) Test method for testing auto-disable feature...15 Bibliography...16 iv ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) Foreword ISO (the International Organization for Standardization) is a worldwide federation of national standards bodies (ISO member bodies). The work of preparing International Standards is normally carried out through ISO technical committees. Each member body interested in a subject for which a technical committee has been established has the right to be represented on that committee. International organizations, governmental and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization. The procedures used to develop this document and those intended for its further maintenance are described in the ISO/IEC Directives, Part 1. In particular the different approval criteria needed for the different types of ISO documents should be noted. This document was drafted in accordance with the editorial rules of the ISO/IEC Directives, Part 2 (see www.iso.org/directives). Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. ISO shall not be held responsible for identifying any or all such patent rights. Details of any patent rights identified during the development of the document will be in the Introduction and/or on the ISO list of patent declarations received (see www.iso.org/patents). Any trade name used in this document is information given for the convenience of users and does not constitute an endorsement. For an explanation on the meaning of ISO specific terms and expressions related to conformity assessment, as well as information about ISO s adherence to the World Trade Organization (WTO) principles in the Technical Barriers to Trade (TBT) see the following URL: www.iso.org/iso/foreword.html. ISO 7886-3 was prepared by Technical Committee ISO/TC 84, Devices for administration of medicinal products and catheters. In some countries national regulations are legally binding and the requirements may take precedence over this International Standard. This second edition cancels and replaces ISO 7886-3:2005, which has been technically revised. ISO 7886 consists of the following parts, under the general title Sterile hypodermic syringes for single use: Part 1: Syringes for manual use Part 2: Syringes for use with power-driven syringe pumps Part 3: Auto-disabled syringes for fixed-dose immunization Part 4: Syringes with re-use prevention feature The main changes to the previous edition of ISO 7886-3 introduced by this revision are: Change in scope of the standard: Upon commencement of injection of a nominal fixed dose of vaccine, the auto-disable feature of the syringe is passively activated so that the syringe cannot be reused. ISO 2016 All rights reserved v
ISO/DIS 7886-3:2016(E) Introduction ISO 7886 was first published in 1984. It was subsequently decided to divide it into two parts, ISO 7886-1 retaining essentially the scope of ISO 7886:1984, and ISO 7886-2 being applicable to sterile, single-use syringes for use with power-driven pumps. The preparation of this third part of ISO 7886 was recognized as a high priority requirement to prevent the re- use of fixed dose immunization syringes in the developing and transitional countries. Re-use of injection equipment in the absence of sterilization has increasingly led to transmission of blood-borne pathogens. The World Health Organization had produced a specification for syringes that are rendered inactive after one use (commonly referred to as auto-disabled syringes). Both the WHO and ISO agreed that an additional part of ISO 7886 would be required to cover auto-disabled syringes, whilst leaving in place ISO 7886 Parts 1 and 2 without modification, as a large number of devices in common use would not be intended to comply with the auto-disable properties suggested. This part of ISO 7886 is intended to cover fixed dose immunization syringes that are passively rendered non-reusable for another application after the commencement of injection intended to deliver a nominal vaccine dose. These syringes are not covered by Parts 1 and 2 of ISO 7886. Based on field feedback, the World Health Organization recommended to make further amendments to this standard for enhanced safety and to bring more clarification to requirements. These amendments are covered in this revision of this standard. It is recognized that syringes designed to reduce the risk of needle stick injuries, may also comply with this part of ISO 7886 with regard to their auto-disable properties, but it is stressed that needle stick protection features of syringes are not in themselves addressed in this part of ISO 7886. Requirements for sharps injury protection features are covered by ISO 23908. Guidance on transition periods for implementing the requirements of this standard is given in ISO/TR 19244 Guidance on transition periods for standards developed by ISO/TC 84 - Devices for administration of medicinal products and catheters. vi ISO 2016 All rights reserved
DRAFT INTERNATIONAL STANDARD ISO/DIS 7886-3:2016(E) Sterile hypodermic syringes for single use Part 3: Auto-disabled syringes for fixed-dose immunization 1 Scope This part of ISO 7886 specifies the properties and performance of sterile single-use hypodermic syringes with or without needle, made of plastic or other materials and intended for the filling and the injection of vaccines immediately after filling. Upon commencement of injection of a nominal fixed dose of vaccine, the auto-disable feature of the syringe is passively activated so that the syringe cannot be reused. This part of ISO 7886 does not specify the design of the auto-disable feature, which is left to the discretion of the manufacturer. This part of ISO 7886 is not applicable to syringes for use with insulin (specified in ISO 8537), syringes for use with power-driven syringe pumps (specified in ISO 7886-2), reuse prevention syringes (specified in ISO 7886-4) and syringes designed to be prefilled. It does not address compatibility with injection fluids/vaccines. NOTE Prefilled syringes are covered under ISO 11040- series. 2 Normative references The following documents, in whole or in part, are normatively referenced in this document and are indispensable for its application. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies ISO 594-1:1986, Conical fittings with a 6 % (Luer) taper for syringes, needles and certain other medical equipment Part 1: General requirements ISO 594-2:1998, Conical fittings with a 6 % (Luer) taper for syringes, needles and certain other medical equipment Part 2: Lock fittings ISO 7864:1993, Sterile hypodermic needles for single use ISO 7886-1:1993, Sterile hypodermic syringes for single use Part 1: Syringes for manual use ISO 8537:2016, Sterile single-use syringes, with or without needle, for insulin ISO 9626, Stainless steel needle tubing for the manufacture of medical devices Requirements and test methods ISO 14971, Medical devices Application of risk management to medical devices ISO 10993-1, Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process ISO 23908, Sharps injury protection Requirements and test methods Sharps protection features for single-use hypodermic needles, introducers for catheters and needles used for blood sampling ASTM D999-08, Standard methods for vibration testing of shipping containers ASTM D5276-98, Standard test method for drop test of loaded containers by free fall NOTE ISO 594-1:1986 Licensed and ISO to: Rundgren, 594-2:1998 Mattis will Mr be replaced by ISO 80369-7. ISO 2016 All rights reserved 1
ISO/DIS 7886-3:2016(E) 3 Terms and definitions For the purposes of this document, the terms and definitions given in ISO 7886-1 (except 3.2) and ISO 8537 (except 3.5) and the following apply. ISO and IEC maintain terminological databases for use in standardization at the following addresses: IEC Electropedia: available at http://www.electropedia.org/ ISO Online browsing platform: available at http://www.iso.org/obp 3.1 auto-disabled syringe feature feature that passively activates upon commencement of injection of the nominal fixed dose to prevent subsequent re-use of the syringe and the needle 3.2 passive activation activation of the reuse prevention feature that does not require an additional step by the user, separate from any action needed to perform the primary intended injection function of the device 3.3 active activation activation of the reuse prevention feature that does require an additional step by the user 3.4 normal conditions of use operation by any user according to the device instructions for use 3.5 integrated needle stainless steel cannula that is directly bonded into the barrel of the syringe 3.6 non-integrated needle hypodermic needle assembly that is fixed or bonded by the manufacturer to the barrel, or a hypodermic needle that is attached by the user prior to making an injection 3.7 barrel flanges flanges that protrude from the barrel (also referred to as finger grips) to provide the user a means of gripping the syringe during injection 3.8 needle cap or shield sheath intended to physically protect the needle prior to use 4 Nomenclature The nomenclature for components of auto-disabled syringes for fixed dose is shown in Figure 1. 2 ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) Key 1 needle cap or shield (if used) 8 fiducial line 2 needle 9 seal(s) 3 zero line 10 barrel flanges (finger grips) 4 barrel 11 plunger 5 auto-disable feature 12 push-button 6 nominal capacity line 13 plunger cap (if used) 7 plunger stopper NOTE The drawing is intended to be illustrative of components of an auto-disabled syringe only. Figure 1 Schematic representation of auto-disabled syringe for fixed dose 5 Requirements 5.1 General Requirements The general requirements listed below are considered to be design input for manufacturers. a) Syringes shall be free from defects affecting appearance, safety and serviceability for their intended use. The syringe s barrel flanges shall be of adequate size, shape and strength for the intended purpose. The design specifications for the barrel flanges shall be determined through risk analysis and confirmed through usability validation testing. The materials shall not cause the syringes to yield, under conditions of normal use, significant amounts of toxic substances and shall permit them to satisfy the Licensed appropriate to: Rundgren, national Mattis requirements Mr or regulations for freedom from pyrogenic ISO 2016 All rights reserved 3
ISO/DIS 7886-3:2016(E) materials and abnormal toxicity. Materials used in the construction of the wall of the syringe barrel shall have sufficient clarity to enable dosages to be read without difficulty. The standard does not specify materials to be used for the construction and lubrication of the device, because their selection will depend, to some extent, upon the manufacturers specific syringe design, process of manufacture and sterilization method. Syringes with integrated or add-on sharps protection shall comply with ISO 23908. b) The length of the barrel shall allow the expulsion of any air bubbles without removal of the plunger stopper and still inject nominal capacity. The length of the barrel shall be designed to enable accurate dosage whilst avoiding unnecessary waste of vaccine. c) The materials used in the syringe shall be tested and qualified according to ISO 10993-1. d) The auto-disabled syringe shall be of adequate size, shape and strength for the delivery of vaccine under normal condition of use. The design specifications for the device shall be determined through risk analysis and confirmed through usability validation testing. e) The forces required to use a syringe with auto-disable feature shall be appropriate for the intended users of the device. Although the activation of the auto-disable feature itself is passive, an appropriate force shall be selected that eases the initiation of the injection. The appropriate initiation force shall be determined using a risk-based approach in accordance with ISO 14971. 6 Cleanliness The surfaces of the syringe and needle that come in contact with the vaccine shall be clean and free from extraneous matter. NOTE Compliance with this requirement will be determined through inspection by an individual with normal vision (or corrected-to-normal vision), without magnification. 7 Limits for acidity or alkalinity When determined with a laboratory ph meter and using a general purpose electrode, the ph value of an extract prepared in accordance with Annex A shall be within one unit of ph of that of the control fluid. 8 Limits for extractable metals When tested by a recognized micro analytical method, for example by an atomic absorption method, an extract prepared in accordance with Annex A shall, when corrected for the metals content of the control fluid, contain no greater than a combined total of 5 mg/l of lead, tin, zinc and iron. The cadmium content of the extract shall, when corrected for the cadmium content of the control fluid, be lower than 0,1 mg/l. 9 Lubricant Clause 7 of ISO 7886-1 and 4.10.4 of ISO 7864 shall apply. 10 Tolerance on nominal capacity The volume of water at (23 ± 5) C expelled from the syringe when the fiducial line of the piston traverses the full scale (i.e. the nominal fixed dose) shall be within the tolerances on the nominal capacity as specified in Table 1. The nominal capacity shall be designated in millilitres. 4 ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) Nominal capacity ml Tolerance on nominal capacity % Table 1 Nominal capacity and dead space Maximum dead space for integrated needle ml Maximum dead space for non-integrated needle ml Maximum displacement of position of scale 0,05ml up to 0,2ml ± 20 % 0,02 0,025 ± 20 % 0,2 >0,2ml up to 0,5ml ± 5 % 0,07 0,07 ± 5 % 5 >0,5ml up to 1,0 ml ± 5 % 0,07 0,07 ± 5 % 10 % Minimal graduation length between the fiducial line and fixed dose mm 11 Graduated scale 11.1 Scale The scale shall have only two markings, the zero line and the nominal capacity line (i.e. the total graduated capacity line). These lines shall be of uniform thickness. They shall lie in planes at right angles to the axis of the barrel. 11.2 Position of scale When the plunger stopper is fully inserted, the zero line of the scale shall coincide with the fiducial line on the plunger stopper to the maximal displacement of position of scale as given in Table 1. 12 Barrel 12.1 Dimensions The length of the barrel and the design of the auto-disable feature shall be such that the maximum usable capacity shall not exceed the nominal capacity by 25 %. 12.2 Barrel flanges 10.2 of ISO 7886-1:1993 shall apply. 13 Plunger stopper/plunger assembly 13.1 Design The design of the plunger and push-button of the syringe shall be such that, when the barrel is held in one hand, the plunger can be depressed by the thumb of that hand. The plunger stopper shall not become detached from the plunger when tested in accordance with Annex B of ISO 8537:2016 for a syringe with integrated needle or in accordance with Annex B of ISO 7886-1:1993 for a syringe without needle. The plunger should be of a length adequate to allow the piston properly to deliver the nominal fixed dose. It should not be possible to defeat the auto-disable feature by removing and re-inserting the plunger. The projection of the plunger and the configuration of the push-button should be such as to allow the plunger to be operated without difficulty. When the fiducial line of the plunger stopper coincides with ISO 2016 All rights reserved 5
ISO/DIS 7886-3:2016(E) the zero graduation line, the preferred minimum length of the plunger from the surface of the barrel flanges nearer to the push-button, as shown in Figure 2, shall be 8 mm. Key 1 Minimum 8 mm Figure 2 Minimum length between barrel flanges and plunger push-button 13.2 Fit of the plunger stopper/plunger in the barrel 13.4 of ISO 7886-1:1993 shall apply. NOTE plunger. Annex B gives a suggested test method and performance criteria for the forces required to move the 13.3 Fiducial line 11.2 of ISO 7886-1:1993 shall apply. 14 Needle 14.1 Integrated needle Syringes with integrated needle shall have a minimum needle union force applied as push or pull in the direction of the needle axis in accordance with ISO 7864. Needle tubing shall be in accordance with ISO 9626. 14.2 Non-integrated needle If a non-integrated needle is used, it shall become an integral part of the syringe and cannot be detached. Both the needle and the syringe shall be rendered incapable of re-use after commencement of injection, under normal conditions of use. For auto-disabled syringes to be connected with a hypodermic needle, the male conical fitting of the syringe nozzle shall be in accordance with ISO 594-1. If the syringe has a locking fitting, it shall be in accordance with ISO 594-2. NOTE ISO 594-1:1986 and ISO 594-2:1998 will be replaced by ISO 80369-7. 14.3 Sharps protection features The device shall meet the requirements of ISO 23908 when an integrated sharps protection feature is provided. 6 ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) The sharps protection feature shall not impede or adversely affect the intended clinical performance of the device, in particular the auto-disable feature of the syringe. 15 Performance 15.1 General The design of the auto-disabled syringe shall be such that it does not prevent the primary intended injection function and manipulations needed to deliver the content. NOTE As an example, for auto-disabled syringes having a breaking plunger mechanism, the strength of the plunger shall ensure normal manipulation of use for aspiration and injection. 15.2 Dead space When a syringe with needle is tested in accordance with Annex D of ISO 8537:2016, the dead space shall not exceed the limits given in Table 1 of 7886-3. 15.3 Freedom from air and liquid leakage When a syringe with integrated needle is tested in accordance with Annex F of ISO 8537:2016 and a syringe without needle is tested in accordance with Annex D of ISO 7886-1:1993, there shall be no leakage of water past the plunger stopper or seal(s). When a syringe with integrated needle is tested in accordance with Annex B of ISO 8537:2016 and a syringe without needle is tested in accordance with Annex B of ISO 7886-1:1993, there shall be no leakage of air past the plunger stopper or seal(s), and there shall be no fall in the manometer reading. For syringes with integrated needle, 5.11.2 of ISO 8537:2016 shall apply. 15.4 Auto-disable feature The syringe and needle shall be passively rendered non-reuseable for another application after the commencement of injection of the nominal vaccine fixed dose. No secondary or additional action on the part of the user shall be required. The auto-disable feature is passively activated and remains effective from the time of commencement of injection. Once the auto-disable feature has been activated, it shall not be possible to override the auto-disable feature when tested in accordance with Annex C, i.e. it shall not be possible to re-use the syringe after applying a force of 100 N at a speed of 100 mm/min on the plunger or a back pressure on the needle of 100 kpa/min up to 300 kpa. 15.5 Performance after shipping There shall be no effect on the performance of the syringe when tested in accordance with ASTM D999-01 and ASTM D5276-98. 15.6 Guidance on materials Guidance on some aspects of the selection of materials is given in Annex E of ISO 7886-1:1993. ISO 2016 All rights reserved 7
ISO/DIS 7886-3:2016(E) 16 Packaging 16.1 Unit packaging providing sterile barrier 14.1.2 of ISO 7886-1:1993 shall apply. 16.2 User packaging 14.3 of ISO 7886-1:1993 shall apply. 17 Information supplied by the manufacturer 17.1 General The syringe shall be accompanied by the information that is sufficient for its safe use, taking account of the training and knowledge of potential users. The information shall include the identity of the manufacturer. 17.2 Syringes The barrels of syringes shall be marked with the following information: a) appropriate graduated scale in accordance with Clause 11; b) total graduated capacity in millilitres. 17.3 Unit packaging providing sterile barrier The unit packaging providing sterile barrier shall bear at least the following information: a) the words for single use or equivalent such as symbol for Do not reuse, per ISO 15223-1. The term disposable shall not be used; NOTE 1 See ISO 15223-1:2012 symbol number 5.4.2 b) the symbol indicating that the auto-disabled syringe prevents re-use as given in Figure 3; c) name and/or trade mark of the manufacturer and where applicable reference to its authorized representative or supplier; d) the word STERILE or equivalent; such as symbol for Sterile, per ISO 15223-1. A warning to check the integrity of the unit packaging before use may be given; such as using the symbol Do not use if package is damaged ; NOTE 2 See ISO 15223-1:2012 symbol number 5.2.1 or symbol number 5.2.2 5.2.5 indicating the sterilization method accordingly. NOTE 3 See ISO 15223-1:2012 symbol number 5.2.8 indicating do not use if packaging is damaged. e) an identification reference to the batch code or lot number, prefixed by the symbol Batch code from ISO 15223-1 or the word LOT ; NOTE 4 See ISO 15223-1:2012 symbol number 5.1.5. f) the words EXP or equivalent such as symbol for Expiration date, per ISO 15223-1. NOTE 5 See ISO 15223-1:2012 symbol number 5.1.4. g) the description of contents including the nominal capacity and type of the needle, if included. 8 ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) 17.4 User packaging The user packaging shall bear at least the following information: a) the words for single use or equivalent such as symbol for Do not reuse, per ISO 15223-1. The term disposable shall not be used; NOTE 1 See ISO 15223-1:2012 symbol number 5.4.2 b) the symbol indicating that the auto-disabled syringe prevents re-use as given in Figure 3; c) name and/or trade mark and address of the manufacturer and where applicable reference to its authorized representative or supplier; d) the word STERILE or equivalent; such as symbol for Sterile, per ISO 15223-1. A warning to check the integrity of the unit packaging before use may be given; such as using the symbol Do not use if package is damaged ; NOTE 2 See ISO 15223-1:2012 symbol number 5.2.1 or symbol number 5.2.2 5.2.5 indicating the sterilization method accordingly. NOTE 3 See ISO 15223-1:2012 symbol number 5.2.8 indicating do not use if packaging is damaged. e) an identification reference to the batch code or lot number, prefixed by the symbol Batch code from ISO 15223-1 or the word LOT ; NOTE 4 See ISO 15223-1:2012 symbol number 5.1.5. f) the words EXP or equivalent such as symbol for Expiration date, per ISO 15223-1. NOTE 5 See ISO 15223-1:2012 symbol number 5.1.4. g) the description of the contents including the nominal capacity and type of the needle, if included; h) a warning to check the integrity of the primary container before use; i) a warning not to recap the needle, or equivalent symbol; j) any information for handling, storage and disposal of syringe; NOTE 6 An example of an illustration of safe disposal of a syringe is given in Figure 4. k) the instructions for use, including the instructions appropriate to the auto-disable feature; alternatively, the instructions for use can be indicated on a separate insert; l) the number of units per secondary container. 17.5 Storage containers The storage container shall bear at least the following information: a) the description of contents including the nominal capacity and the type of needle, if included; b) the symbol indicating that the auto-disabled syringe prevents re-use as given in Figure 3; c) an identification reference to the batch code or lot number, prefixed by the symbol Batch code from ISO 15223-1 or the word LOT ; NOTE 1 See ISO 15223-1:2012 symbol number 5.1.5. d) the words EXP or equivalent such as symbol for Expiration date, per ISO 15223-1. NOTE 2 See ISO 15223-1:2012 symbol number 5.1.4. ISO 2016 All rights reserved 9
ISO/DIS 7886-3:2016(E) e) the word STERILE or equivalent; such as symbol for Sterile, per ISO 15223-1. A warning to check the integrity of the unit packaging before use may be given; such as using the symbol Do not use if package is damaged ; NOTE 3 See ISO 15223-1:2012 symbol number 5.2.1 or symbol number 5.2.2 5.2.5 indicating the sterilization method accordingly. NOTE 4 See ISO 15223-1:2012 symbol number 5.2.8 indicating do not use if packaging is damaged. f) name and/or trade mark and address of the manufacturer and where applicable reference to its authorized representative or supplier; g) any information for handling, storage and transportation of the contents (or equivalent symbols as given in ISO 7000 or ISO 780); NOTE 5 An indication to keep the storage container away from sunlight and keep dry may be given. See ISO 15223-1:2012 symbol numbers 5.3.2 and 5.3.4. h) the number of units per storage container. 17.6 Transport wrapping If a storage container is not used but the secondary containers are wrapped for transportation, the information required by 17.5 shall either be marked on the wrapping or shall be visible through the wrapping. Figure 3 Re-use prevention (ISO 7000-2655) 10 ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) Figure 4 Example of a diagram to illustrate safe disposal of syringe ISO 2016 All rights reserved 11
ISO/DIS 7886-3:2016(E) Annex A (normative) Method for preparation of extracts A.1 Principle The syringe, including the needle (if available), is filled with water in order to extract soluble components. A.2 Apparatus and reagents A.2.1 Distilled water A.2.2 Laboratory borosilicate glassware A.3 Procedure A.3.1 Fill at least three syringes to the nominal capacity graduation line with water (A.2.1), expel air bubbles and maintain the syringes, including the needle, at a temperature of 37 C to 40 C for 8 h to 8 h 15 min. Eject the contents and combine them in a vessel made of borosilicate glass (A.2.2). A.3.2 NOTE Prepare the control fluid by reserving a portion of the unused water (A.2.1). The number of required syringes to be filled may increase for small volume syringes. 12 ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) Annex B (informative) Test method for forces required to operate piston B.1 Principle A mechanical testing machine (see Figure E.1 in ISO 7886-1:1993) is used to move the syringe plunger and to aspirate and expel water, whilst the force exerted and the plunger travel are recorded. B.2 Apparatus and reagents B.2.1 Mechanical testing machine, capable of measuring and continuously recording force and travel with an accuracy of 1 % of full scale reading and having means for attaching the syringe to be tested. B.2.2 Reservoir for testing non-integrated needle type, open to the atmosphere, and having tubing of inside diameter (2,7 ± 0,1) mm and (19.5 ± 0,5) in length and sufficient flexibility for connecting it to the syringe to be tested via a female Luer to barbed adapter and to the outlet needle (1,2 mm or 18G x approximately 10cm long) via a male Luer to barbed adapter. B.2.3 Reservoir for testing integrated needle type, open to the atmosphere, and having tubing of inside diameter (2,7 ± 0,1) mm and (19.5 ± 0,5) in length and sufficient flexibility for connecting it to the syringe to be tested by closing with a rubber stopper for connecting it to the integrated needle of the syringe to be tested. B.2.4 Distilled water. B.3 Procedure B.3.1 B.3.2 Remove the syringe from the package and mount it in the testing machine (B.2.1). Connect the syringe using one of the following procedures. Testing non-integrated needle type. Connect the nozzle of the syringe to the tubing of the reservoir (B.2.2). Add water (B.2.4) at (23 ± 5) C to the reservoir and displace any air from the tubing. Maintain the water and the syringe at this temperature. Adjust the relative positions of the syringe and reservoir so that the water level in the reservoir is approximately level with the mid-point of the syringe barrel. Testing integrated needle type. Connect the needle of the syringe to the rubber stopper of the tubing of the reservoir (B.2.3). Add water (B.2.4) at (23 ± 5) C to the reservoir and displace any air from the tubing. Maintain the water and the syringe at this temperature. Adjust the relative positions of the syringe and reservoir so that the water level in the reservoir is approximately level with the mid-point of the syringe barrel. B.3.3 Zero the recorder and set the testing machine (B.2.1) so that it can apply compressive and tensile forces without re-setting. ISO 2016 All rights reserved 13
ISO/DIS 7886-3:2016(E) B.3.4 Start the testing machine so that it withdraws the syringe plunger, at a rate of (100 ± 5) mm/min, to the graduation line that indicates the nominal capacity, thereby drawing water from the reservoir to the syringe. Stop the plunger travel and readjust the recorder to zero. Wait 30 s. NOTE The presence of air in the syringe nozzle or needle, irrespective of whether the syringe is of the nonintegrated or integrated needle type, will not affect the results of the test. B.3.5 Reverse the testing machine and return the plunger so that the fiducial line reaches the zero graduation line, thereby expelling the water from the syringe into the reservoir. B.4 Calculation of results B.4.1 From the recording of plunger travel and force applied (see Figure E.2 in ISO 7886-1:1993), determine the following: a) the force required (F s ) to initiate movement of the plunger, i.e. the peak force recorded when the testing machine starts to withdraw the plunger (see B.3.4); b) the mean force (F) during return of the plunger [i.e. the estimated or integrated mean value while the testing machine is returning the plunger (see B.3.5)]; c) the maximum force (F max ) during return of the plunger (see B.3.5); d) the minimum force (F min ) during return of the plunger (see B.3.5). B.4.2 Proposed values for the forces required to operate the plunger are given in Table B.1. Table 2 Proposed values for forces required to operate plunger Nominal capacity of syringe V ml Maximum initial force F s N Mean force V < 2 10 9 B.5 Test report F N Maximum force F max N 2 measured F or measured F + 1,5 N whichever is the higher Minimum force F min N 0,5 measured F or measured F + 1,5 N whichever is the lower The test report shall contain at least the following information: a) the identity and nominal capacity of syringe; b) the force (F s ) required to initiate movement of the plunger, expressed in newtons; c) the mean force (F) during return of the plunger, expressed in newtons; d) the maximum force (F max ) during return of the plunger, expressed in newtons; e) the minimum force (F min ) during return of the plunger, expressed in newtons; f) the date of testing. 14 ISO 2016 All rights reserved
ISO/DIS 7886-3:2016(E) Annex C (normative) Test method for testing auto-disable feature C.1 Principle After delivery of a full dose of vaccine or distilled water under normal conditions of use, a mechanical testing machine or pressure device is used to move the plunger out of the barrel and the force required to move the plunger and/or to destroy the barrel is measured and recorded. C.2 Apparatus C.2.1 Device for applying an axial force, up to a maximum of 100 N while moving the plunger with a speed of 100 mm/min. C.2.2 Device to apply a back-pressure, at a rate of approximately 100 kpa/min for an applied pressure of up to 300 kpa. C.3 Procedure C.3.1 Deliver a full dose of vaccine or distilled water under normal conditions of use. Using the test device (C.2.1) impose an increasing force on the plunger to withdraw it from the barrel using the thumb plate or the plunger as the grip. Move the plunger at a speed of 100 mm/min. Increase the force to a maximum of 100 N or until the plunger is capable of delivering a second dose from the same syringe. C.3.2 Using the test device (C.2.2), subject the syringe needle to a slowly increasing back pressure at approximately 100 kpa/min up to 300 kpa, and record whether the plunger stopper or seal(s) can be driven back in the syringe barrel. C.4 Test report The test report shall contain at least the following information: a) the identity and nominal capacity of the syringe; b) the maximum force applied; c) the maximum pressure applied; d) the date of testing. ISO 2016 All rights reserved 15
ISO/DIS 7886-3:2016(E) Bibliography [1] ISO 780:1997, Packaging Pictorial marking for handling of goods [2] ISO 7000:2004, Graphical symbols for use on equipment Index and synopsis 16 ISO 2016 All rights reserved